EX-10.1
Shuttle Pharmaceuticals Holdings, Inc.
** **
FIRST AMENDMENT TO MERGER AGREEMENT
** **
This First Amendment to Merger Agreement (this “Amendment”) is made and entered into as of August 31, 2026 (the “Effective Date”) by and between Shuttle Pharmaceutical Holdings, Inc. (“Acquiror”) and United Dogecoin Inc., on its own behalf (the “Company”) and as successor-in-interest to Shuttle Merger Sub Inc. (“Merger Sub”; Acquiror, the Company and Merger Sub are collectively referred to herein as the “Parties” and individually as a “Party”).
WHEREAS, the Parties entered into that certain Agreement and Plan of Merger, dated as of April 30, 2026 (the “Agreement”; capitalized terms used in this Amendment shall have the meanings indicated in the Agreement) pursuant to which Merger Sub was merged with and into the Company as a result of which the Company became a wholly-owned subsidiary of Acquiror; and
WHEREAS, the Parties desire to amend the Agreement to amend the Milestone Events provided for therein; and
…